RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4179
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0414800; Gene model (P.falciparum): PF3D7_0906500; Gene product: arginase
Phenotype Liver stage;
Last modified: 29 June 2017, 13:08
  *RMgm-4179
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 28642498
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherMeireles P, PrudĂȘncio M
Name Group/DepartmentInstituto de Medicina Molecular, Faculdade de Medicina
Name InstituteUniversidade de Lisboa
CityLisboa
CountryPortugal
Name of the mutant parasite
RMgm numberRMgm-4179
Principal namearginase-KO clone 2
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageIn this paper only liver stage development has been analysed. Evidence is presented that infectivity of part of the sporozoites is affected (see Additional Information).
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of arginase

Protein (function)
L-arginine (Arg), a cationic amino acid, catalyzes the hydrolysis of Arg and its activity is important for maintaining ornithine levels for polyamine synthesis. Plasmodium parasites  express arginase and the dependency of blood-stage P. falciparum on polyamines for survival has been well established.
In the paper evidence is presented that L-arginine (Arg) uptake through the hepatocyte cell’s SLC7A2-encoded transporters is essential for the parasite’s development and maturation in the liver.Although the parasite may hijack the host’s biosynthesis pathway, it relies mainly upon its own arginase-AdoMetDC/ODC pathway to acquire the polyamines it needs to develop.

Phenotype
In this paper only liver stage development has been analysed. Evidence is presented that infectivity of part of the sporozoites is affected (see Additional Information).

Additional information
Evidence is presented for a bimodal pattern for the relative infectivity of both clones of the arginase-KO parasite. Of a total of 12 independent in vitro experiments performed with each of the clones, similar infection loads for WT and arginase-KO parasites were observed in approximately half of them, and a significantly lower infection by the arginase-KO parasite in the remaining half. These observations were also reproduced in an in vivo setting where the liver parasite loads were compared of mice infected with WT and arginase-KO P. berghei parasites. 8 and 5 independent rodent infection studies were carried out with arginase-KO clone #1 RMgm-228 and clone #2, respectively, and consistently a bimodal behavior was found of either arginase-KO parasite clone, similar to that observed in vitro . When employed in parallel in vitro and in vivo experiments, each independent batch of arginase-KO parasites always behaved similarly in the two experimental settings. Finally, it was investigated whether infection by the arginase-KO clone #1 parasite would be impacted by the down-modulation of the expression of the host’s enzymes involved in polyamine synthesis. When the parasite displayed impaired hepatic infectivity, the knock-down of the host’s ODC or arginase I enzymes did not further impact infection. However, when the in vitro infectivity of the arginase-KO parasite was similar to that of the WT, the knock-down of the expression of the host’s enzymes led to a decrease in infection.

It is concluded that these results suggest that the parasite relies primarily on its own polyamine synthesis pathway for hepatic development and also indicate that the parasite is able to circumvent the absence of its own polyamine biosynthesis machinery and rely on the host’s pathway to acquire the polyamines it needs to develop.

Other mutants
RMgm-228 - another mutant lacking expression of arginase (arginase-KO clone 1).


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0414800
Gene Model P. falciparum ortholog PF3D7_0906500
Gene productarginase
Gene product: Alternative name
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6